Similar to other EBV-associated neoplasias, such as nasopharyngeal lesions, gastric carcinoma, and Hodgkin lymphoma, the expression of PD-L1 by NK/T lymphoma cells is likely to be involved in this resistance. This evidence concerns the gene CD274 and neoplasm.